Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET
dc.contributor.author | Stage, Eddie | |
dc.contributor.author | Risacher, Shannon L. | |
dc.contributor.author | Lane, Kathleen A. | |
dc.contributor.author | Gao, Sujuan | |
dc.contributor.author | Nho, Kwangsik | |
dc.contributor.author | Saykin, Andrew J. | |
dc.contributor.author | Apostolova, Liana G. | |
dc.contributor.author | Alzheimer’s Disease Neuroimaging Initiative | |
dc.contributor.department | Neurology, School of Medicine | en_US |
dc.date.accessioned | 2023-06-16T14:24:23Z | |
dc.date.available | 2023-06-16T14:24:23Z | |
dc.date.issued | 2022-05-11 | |
dc.description.abstract | Introduction: We previously reported genetic associations of the top Alzheimer's disease (AD) risk alleles with amyloid deposition and neurodegeneration. Here, we report the association of these variants with [18F]flortaucipir standardized uptake value ratio (SUVR). Methods: We analyzed the [18F]flortaucipir scans of 352 cognitively normal (CN), 160 mild cognitive impairment (MCI), and 54 dementia (DEM) participants from Alzheimer's Disease Neuroimaging Initiative (ADNI)2 and 3. We ran step-wise regression with log-transformed [18F]flortaucipir meta-region of interest SUVR as the outcome measure and genetic variants, age, sex, and apolipoprotein E (APOE) ε4 as predictors. The results were visualized using parametric mapping at familywise error cluster-level-corrected P < .05. Results: APOE ε4 showed significant (P < .05) associations with tau deposition across all disease stages. Other significantly associated genes include variants in ABCA7 in CN, CR1 in MCI, BIN1 and CASS4 in MCI and dementia participants. Discussion: We found significant associations to tau deposition for ABCA7, BIN1, CASS4, and CR1, in addition to APOE ε4. These four variants have been previously associated with tau metabolism through model systems. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Stage E, Risacher SL, Lane KA, et al. Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET. Alzheimers Dement (Amst). 2022;14(1):e12308. Published 2022 May 11. doi:10.1002/dad2.12308 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/33813 | |
dc.language.iso | en_US | en_US |
dc.publisher | Alzheimer’s Association | en_US |
dc.relation.isversionof | 10.1002/dad2.12308 | en_US |
dc.relation.journal | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | Alzheimer's disease | en_US |
dc.subject | Alzheimer's Disease Neuroimaging Initiative | en_US |
dc.subject | Flortaucipir | en_US |
dc.subject | Imaging genetics | en_US |
dc.subject | Risk genes | en_US |
dc.title | Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET | en_US |
dc.type | Article | en_US |